PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
154 hedge funds and large institutions have $347M invested in PDL BioPharma, Inc. in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 63 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
51% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 63
Holders
154
Holding in Top 10
–
Calls
$148K
Puts
$50K
Top Buyers
| 1 | +$1.53M | |
| 2 | +$1.35M | |
| 3 | +$1.22M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$941K |
| 5 |
Citigroup
New York
|
+$905K |
Top Sellers
| 1 | -$4.73M | |
| 2 | -$3.1M | |
| 3 | -$2.82M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.25M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.83M |